General Information of the Compound
Compound ID
CP0454317
Compound Name
5-(2-pyrrolidin-1-ylethyl)-1,2-thiazole
    Show/Hide
Synonyms
5-(2-(pyrrolidin-1-yl)ethyl)isothiazole
CHEMBL272131
    Show/Hide
Structure
Formula
C9H14N2S
Molecular Weight
182.292
Canonical SMILES
C(Cc1ccns1)N1CCCC1
    Show/Hide
InChI
InChI=1S/C9H14N2S/c1-2-7-11(6-1)8-4-9-3-5-10-12-9/h3,5H,1-2,4,6-8H2
    Show/Hide
InChIKey
GRXWPIZSBSTAQX-UHFFFAOYSA-N
Physicochemical Property
logP
1.7814
Rotatable Bonds
3
Heavy Atom Count
12
Polar Areas
16.13
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
3
Complexity
12

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44456451
ChEMBL ID
CHEMBL272131
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01194, Histamine H3 receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 190 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 5-(2-(pyrrolidin-1-yl)ethyl)isothiazole )
Drug Name 5-(2-(pyrrolidin-1-yl)ethyl)isothiazole
Target(s)
Histamine H3 receptor (H3R)
Inhibitor